Speaker illustration

Professor Bronwyn Kingwell

CSL Ltd, Melbourne (Australia)

CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes


CSL112 (human apolipoprotein A-I) infusion rapidly increases apoA-I exchange rate (AER) when administered to patients post myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters


Acute coronary syndromes: mechanistic insights and risk prediction through lipoprotein lipidomics

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session: Pathophysiology of coronary artery diseases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb